MENU
ENTX
AS OF
Dec 26, 04:59 PM (EDT)
Price
$1.74
Change
-$0.00 (-0.00%)
Capitalization
79.79M
91 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ENTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Entera Bio (ENTX) Ownership - Who owns Entera Bio?

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
Minrav Building - Fifth Floor
Phone
+972 25327151
Employees
19
Web
https://www.enterabio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
79.79M
P/E Ratio
N/A
Total Cash
8.57M
Projected Growth
N/A
Total Debt
211K
Revenue
124K
Risk (Beta)
0.58
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price

Fundamentals

ENTX
Capitalization
79.8M
P/E Ratio
N/A
Risk (Beta)
0.58
Dividend Yield
N/A
Total Cash
8.57M
Total Cash/Share
0.19
Total Debt
211K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
124K
ROE
N/A
Book Value
15.2M
P/B Ratio
5.24
Cash Flow
N/A
Earnings
-0.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
10.83
Current Revenue Per Employee
2100.00
Dividends Per Share - Security
N/A
EBITDA
-10.79M
Float
N/A
Float - Current
N/A
Gross Income Margin
0.00
Revenue To Assets
-85.74
Shares Held By Institutions
17.7M
Shares Outstanding - Current
45.9M
Total Liabilities
2.17M
Total Volume MTD
N/A
Value
-1
Gain YTD
-17.925
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ENTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ENTX showed earnings on November 14, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ENTX
A.I. Advisor
published General Information

General Information

a manufacturer of flu medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Minrav Building - Fifth Floor
Phone
+972 25327151
Employees
19
Web
https://www.enterabio.com